From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer

The current management of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) is based on systemic chemotherapy. The results of the MPACT and PRODIGE clinical trials have demonstrated that the combination of nab-paclitaxel and gemcitabine (GEM) as well as FOLFIRINOX regimen result in i...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín, Andrés Muñoz, Hidalgo, Manuel, Alvarez, Rafael, Arrazubi, Virginia, Martínez-Galán, Joaquina, Salgado, Mercedes, Macarulla, Teresa, Carrato, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995948/
https://www.ncbi.nlm.nih.gov/pubmed/29896283
http://dx.doi.org/10.7150/jca.23716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995948/
https://www.ncbi.nlm.nih.gov/pubmed/29896283
http://dx.doi.org/10.7150/jca.23716

Ejemplares similares